1 型多发性内分泌肿瘤综合征的临床试验
总计14017个结果
-
AstraZenecaAstra Zeneca, Bristol-Myers Squibb完全的
-
Sansum Diabetes Research InstituteUniversity of California, Santa Barbara完全的
-
Oregon Health and Science UniversityThe Leona M. and Harry B. Helmsley Charitable Trust完全的
-
University of VirginiaUniversity Hospital, Montpellier; University of Padova; University of California, Santa Barbara完全的
-
University of HelsinkiNovo Nordisk A/S; Juvenile Diabetes Research Foundation; European Union; Academy of Finland; Diabetes...完全的
-
Spiden AGDCB Research AG完全的
-
Poznan University of Medical Sciences未知
-
SpringWorks Therapeutics, Inc.主动,不招人
-
SpringWorks Therapeutics, Inc.可用的神经纤维瘤病 1 型相关丛状神经纤维瘤 | 组织细胞肿瘤 | 其他 MAP-K 通路驱动的疾病
-
Institut de Recherches Cliniques de MontrealMcGill University Health Centre/Research Institute of the McGill University Health Centre招聘中
-
Children's National Research InstituteAmerican Diabetes Association主动,不招人
-
Nemours Children's ClinicWashington University School of Medicine; Yale University; University of Iowa; National Institutes... 和其他合作者完全的
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
University of Kansas Medical Center完全的
-
Eli Lilly and Company完全的1 型糖尿病美国, 捷克语, 法国, 西班牙, 日本, 德国, 意大利, 巴西, 丹麦, 奥地利, 英国, 中国, 俄罗斯联邦, 墨西哥, 波兰, 乌克兰, 以色列, 波多黎各
-
King's College LondonKing's College Hospital NHS Trust; Juvenile Diabetes Research Foundation; Guy's and St Thomas'... 和其他合作者完全的
-
Stanford UniversityUniversity of Colorado, Denver; University of South Florida; Indiana University完全的
-
LMC Diabetes & Endocrinology Ltd.未知
-
Oshadi Drug Administration完全的